RECCE PHARMACEUTICALS LTD — Share Issue/Capital Change 2024

Feb 26, 2024

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Announcement Type

New announcement

Date of this announcement

Tuesday February 27, 2024

Details of +securities that have ceased

		Number of
ASX +security		+securities that	The +securities have	Date of
code	Security description	have ceased	ceased due to	cessation
RCEAU	OPTION EXPIRING	206,870	Expiry of option or other	19/12/2023
	VARIOUS DATES EX		convertible security without
	VARIOUS PRICES		exercise or conversion

Refer to next page for full details of the announcement

Appendix 3H - Notification of cessation of securities

1 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Announcement Details

1.1 Name of +Entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type Registration Number ACN 124849065

1.3 ASX issuer code

RCE

1.4 The announcement is

New announcement

1.5 Date of this announcement

27/2/2024

Appendix 3H - Notification of cessation of securities

2 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased

206,870

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation Is the entity paying any consideration for the cessation? No 19/12/2023

Any other information the entity wishes to notify to ASX about the cessation?

Appendix 3H - Notification of cessation of securities

3 / 4

Appendix 3H - Notification of cessation of securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
RCE : ORDINARY FULLY PAID	203,701,863

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
RCEAH : PERFORMANCE SHARES	8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56	435,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	1,125,000
RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56	8,415,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Appendix 3H - Notification of cessation of securities

4 / 4